In vivo delivery of adenoviral vector containing interleukin-17 receptor a reduces cardiac remodeling and improves myocardial function in viral myocarditis leading to dilated cardiomyopathy.
In vivo delivery of adenoviral vector containing interleukin-17 receptor a reduces cardiac remodeling and improves myocardial function in viral myocarditis leading to dilated cardiomyopathy.
复制标题
DOI:
10.1371/journal.pone.0072158
复制
发表时间:
2013
期刊:
影响因子:
3.7
通讯作者:
Chen R
中科院分区:
文献类型:
--
作者:
Xie Y;Li M;Wang X;Zhang X;Peng T;Yang Y;Zou Y;Ge J;Chen H;Chen R
Th17 cells have been implicated in the pathogenesis of myocarditis. Interleukin (IL)-17A produced by Th17 cells is dispensable for viral myocarditis but essential for the progression to dilated cardiomyopathy (DCM). This study investigated whether the adenoviral transfer of the IL-17 receptor A reduces myocardial remodeling and dysfunction in viral myocarditis leading to DCM. In a mouse model of Coxsackievirus B3 (CVB3)-induced chronic myocarditis, the delivery of the adenovirus-containing IL-17 receptor A (Ad-IL17RA:Fc) reduced IL-17A production and decreased the number of Th17 cells in the spleen and heart, leading to the down-regulation of systemic TNF-α and IL-6 production. Cardiac function improved significantly in the Ad-IL17R:Fc- compared with the Ad-null-treated mice 3 months after the first CVB3 infection. Ad-IL17R:Fc reduced the left ventricle dilation and decreased the mortality in viral myocarditis, leading to DCM (56% in the Ad-IL17R:Fc versus 76% in the Ad-null group). The protective effects of Ad-IL17R-Fc on remodeling correlated with the attenuation of myocardial collagen deposition and the reduction of fibroblasts in CVB3-infected hearts, which was accompanied by the down-regulation of A distintegrin and metalloprotease with thrombospondin type 1 motifs (ADAMTS-1), Matrix metalloproteinase-2(MMP-2), and collagen subtypes I and III in the heart. Moreover, in cultured cardiac fibroblasts, IL-17A induced the expression of ADAMTS-1, MMP-2, and collagen subtypes I and III and increased the proliferation of fibroblasts. We determined that the delivery of IL-17-RA:Fc reduces cardiac remodeling, improves function, and decreases mortality in viral myocarditis leading to DCM, possibly by suppressing fibrosis. Therefore, the adenoviral transfer of the IL-17 receptor A may represent an alternative therapy for chronic viral myocarditis and its progression to DCM.
登录
查看更多内容
影响因子:
37.8
作者:
Eriksson, U;Kurrer, MO;Kopf, M
通讯作者:
Kopf, M
影响因子:
37.8
作者:
Smith E;Prasad KM;Butcher M;Dobrian A;Kolls JK;Ley K;Galkina E
通讯作者:
Galkina E
DOI:
10.1084/jem.194.4.519
发表时间:
2001-08-20
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Ye P;Rodriguez FH;Kanaly S;Stocking KL;Schurr J;Schwarzenberger P;Oliver P;Huang W;Zhang P;Zhang J;Shellito JE;Bagby GJ;Nelson S;Charrier K;Peschon JJ;Kolls JK
通讯作者:
Kolls JK
影响因子:
4
作者:
Yan, Shu;Wang, Luman;Chu, Yiwei
通讯作者:
Chu, Yiwei
影响因子:
3.5
作者:
Kuno, K;Okada, Y;Matsushima, K
通讯作者:
Matsushima, K